Aspen Aerogels, Inc. (NYSE:ASPN) Receives $5.19 Consensus PT from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has earned an average recommendation of “Hold” from the six analysts that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $5.1875.

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Roth Mkm reaffirmed a “buy” rating and issued a $5.75 price target on shares of Aspen Aerogels in a research note on Friday, May 8th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Barclays increased their price objective on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research note on Monday, May 11th.

Aspen Aerogels Price Performance

ASPN stock opened at $5.58 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.54 and a current ratio of 2.89. Aspen Aerogels has a 52 week low of $2.30 and a 52 week high of $9.78. The firm’s fifty day moving average is $5.44 and its 200 day moving average is $4.08. The firm has a market cap of $462.47 million, a P/E ratio of -4.10 and a beta of 2.98.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The business had revenue of $37.88 million during the quarter, compared to the consensus estimate of $36.58 million. During the same period in the prior year, the firm earned ($0.06) earnings per share. The business’s revenue for the quarter was down 51.8% on a year-over-year basis. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Research analysts predict that Aspen Aerogels will post -0.8 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the company. Acadian Asset Management LLC purchased a new position in shares of Aspen Aerogels in the first quarter valued at about $43,000. Tower Research Capital LLC TRC boosted its holdings in shares of Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after purchasing an additional 4,693 shares during the period. Royal Bank of Canada boosted its holdings in shares of Aspen Aerogels by 95.8% during the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company’s stock worth $29,000 after purchasing an additional 4,169 shares during the period. Prelude Capital Management LLC bought a new stake in shares of Aspen Aerogels in the third quarter worth about $70,000. Finally, Balance Wealth LLC bought a new stake in shares of Aspen Aerogels in the fourth quarter worth about $29,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.